- Home
- ONDS vs NBTX Comparison
ONDS vs NBTX Comparison
Compare ONDS & NBTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ONDS
- NBTX
- Stock Information
- Founded
- ONDS 2014
- NBTX 2003
- Country
- ONDS United States
- NBTX France
- Employees
- ONDS N/A
- NBTX N/A
- Industry
- ONDS Telecommunications Equipment
- NBTX Biotechnology: Pharmaceutical Preparations
- Sector
- ONDS Telecommunications
- NBTX Health Care
- Exchange
- ONDS Nasdaq
- NBTX Nasdaq
- Market Cap
- ONDS 218.8M
- NBTX 201.9M
- IPO Year
- ONDS N/A
- NBTX 2020
- Fundamental
- Price
- ONDS $2.07
- NBTX $3.03
- Analyst Decision
- ONDS Buy
- NBTX Strong Buy
- Analyst Count
- ONDS 1
- NBTX 1
- Target Price
- ONDS $4.00
- NBTX $12.00
- AVG Volume (30 Days)
- ONDS 11.0M
- NBTX 42.0K
- Earning Date
- ONDS 11-12-2024
- NBTX 09-18-2024
- Dividend Yield
- ONDS N/A
- NBTX N/A
- EPS Growth
- ONDS N/A
- NBTX N/A
- EPS
- ONDS N/A
- NBTX N/A
- Revenue
- ONDS $8,024,937.00
- NBTX $45,220,186.00
- Revenue This Year
- ONDS N/A
- NBTX N/A
- Revenue Next Year
- ONDS $279.95
- NBTX N/A
- P/E Ratio
- ONDS N/A
- NBTX N/A
- Revenue Growth
- ONDS N/A
- NBTX 526.17
- 52 Week Low
- ONDS $0.54
- NBTX $2.76
- 52 Week High
- ONDS $3.40
- NBTX $8.43
- Technical
- Relative Strength Index (RSI)
- ONDS 52.50
- NBTX 46.58
- Support Level
- ONDS $1.82
- NBTX $2.85
- Resistance Level
- ONDS $2.27
- NBTX $3.07
- Average True Range (ATR)
- ONDS 0.42
- NBTX 0.16
- MACD
- ONDS -0.10
- NBTX 0.04
- Stochastic Oscillator
- ONDS 15.82
- NBTX 45.65
About ONDS Ondas Holdings Inc.
Ondas Holdings Inc designs, develops, manufactures, sells, and supports FullMAX Software Defined Radio (SDR) technology in the United States, Israel, and India. The company operates in two business segments namely Ondas Networks and Ondas Autonomous Systems. The company generates maximum revenue from Ondas Autonomous Systems through the sales of the Optimus system and separately priced support, maintenance, and ancillary services related to the sale of the Optimus system.
About NBTX Nanobiotix S.A.
Nanobiotix SA is a clinical-stage biotechnology company that has one operating segment, which focuses on developing product candidates that use its proprietary nanotechnology to transform cancer treatment by increasing the efficacy of radiotherapy. The company develops NanoXray products to help patients receiving radiotherapy by magnifying the effect of radiotherapy within tumor cells without increasing the dose to surrounding healthy tissues. Its product candidate is NBTXR3, a preclinical research program for cancer immunotherapies.